These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6162766)

  • 1. Natural protease inhibitors to fibrinolysis in liver diseases.
    Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
    Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitors of serum proteinases].
    Jendryczko A; Drózdz M
    Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on physiological inhibitors of coagulation and fibrinolysis in hepatobiliary diseases and acute pancreatitis (author's transl)].
    Yoshimura R; Satake K
    Rinsho Ketsueki; 1978 Jul; 19(7):927-33. PubMed ID: 81327
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in fibrinolysis in liver cirrhosis].
    Fontcuberta J; Borrell M; Felez J; Elez I; López M; Remacha A; Rutllant ML
    Sangre (Barc); 1982; 27(4-B):727-36. PubMed ID: 6186038
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum protease inhibitors in opisthorchiasis, hepatoma, cholangiocarcinoma, and other liver diseases.
    Changbumrung S; Migasena P; Supawan V; Juttijudata P; Buavatana T
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):299-305. PubMed ID: 2465579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the fibrinolytic enzyme system.
    Aoki N; Harpel PC
    Semin Thromb Hemost; 1984 Jan; 10(1):24-41. PubMed ID: 6199845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J; Dhennin C; Guilbaud J
    Nouv Rev Fr Hematol (1978); 1982; 24(6):375-81. PubMed ID: 6188103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors in liver disease.
    Sinclair TS; Booth NA; Penman SM; Brunt PW; Mowat NA; Bennett NB
    Scand J Gastroenterol; 1988 Jun; 23(5):620-4. PubMed ID: 2456604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of fibronectin and protease inhibitors in chronic obstructive pulmonary diseases].
    Dong BR
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Dec; 12(6):343-6, 381. PubMed ID: 2483984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of fibrinolysis in orthotopic liver transplantation.
    Cheema SP; Webster NR; Dunn F; Bellamy MC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Components of the kallikrein-kinin-system in patients with ARDS.
    Fuhrer G; Heller W; Junginger W; Gröber O; Roth K
    Prog Clin Biol Res; 1989; 308():737-42. PubMed ID: 2476827
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated intravascular coagulation and antiprotease activity in acute human pancreatitis.
    Lasson A; Ohlsson K
    Scand J Gastroenterol Suppl; 1986; 126():35-9. PubMed ID: 2436283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbation of protease inhibitors and substrates in inflammatory arthritis.
    Rothschild BM; Thompson LD; Pifer DD; Chesney CM
    Semin Thromb Hemost; 1985 Oct; 11(4):394-404. PubMed ID: 2416060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):155-9. PubMed ID: 7536112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood levels of proteinase inhibitors in pre-eclampsia.
    Gow L; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1983 Oct; 90(10):950-2. PubMed ID: 6194812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of the natural inhibitors to coagulation and fibrinolysis in cases of renal diseases (author's transl)].
    Nakamura K; Kazama M
    Rinsho Ketsueki; 1978 Jul; 19(7):934-9. PubMed ID: 81328
    [No Abstract]   [Full Text] [Related]  

  • 19. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulopathy following major liver resection: the effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver.
    Meijer C; Wiezer MJ; Hack CE; Boelens PG; Wedel NI; Meijer S; Nijveldt RJ; Statius Muller MG; Wiggers T; Zoetmulder FA; Borel Rinkes IH; Cuesta MA; Gouma DJ; van de Velde CJ; Tilanus HW; Scotté M; Thijs LG; van Leeuwen PA
    Shock; 2001 Apr; 15(4):261-71. PubMed ID: 11303724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.